SEC Form 4
Celularity Inc. (CELU) insider trading
No open-market CELU insider purchases or sales were filed in the 12 months to Oct 26, 2026.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $0
- 0 filings · 0 insiders
- Open-market purchases
- $0
- 0 filings
Who traded CELU, and when
CELU daily close from Oct 27, 2025 to Oct 26, 2026, between $0.60 and $2.10, last $0.75. No open-market insider purchases or sales were filed in this period.
No open-market insider purchases or sales were filed in the last 12 months.
Open-market trades
0 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| No open-market purchases or sales in the last 12 months. | ||||||
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
| No open-market purchases or sales in the last 12 months. | |||||||
GET /stocks/filings/vX/form-4?tickers=CELU&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"CELU"
],
"issuer_cik": "0001752828",
"owner_cik": "0002106805",
"accession_number": "0001104659-26-111026",
"form_type": "4",
"filing_date": "2026-09-25",
"period_of_report": "2026-09-23",
"issuer_name": "Celularity Inc",
"issuer_trading_symbol": "CELU",
"owner_name": "Barach Philip Alan",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": true,
"is_other": false,
"security_type": "derivative",
"record_type": "holding",
"security_title": "Warrants",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"shares_owned_following_transaction": 2448917,
"exercise_price": 2,
"exercise_date": "2026-06-19",
"expiration_date": "2030-12-19",
"underlying_security_title": "Class A Common Stock",
"underlying_security_shares": 2448917,
"not_subject_to_section_16": false,
"direct_or_indirect": "I",
"nature_of_ownership": "See Footnote",
"footnotes": [
{
"id": "F2",
"description": "The Philip and Daniele Barach Family Trust (the \"Trust\") is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein."
}
]
},
{
"tickers": [
"CELU"
],
"issuer_cik": "0001752828",
"owner_cik": "0002126385",
"accession_number": "0001104659-26-111027",
"form_type": "4",
"filing_date": "2026-09-25",
"period_of_report": "2026-09-23",
"issuer_name": "Celularity Inc",
"issuer_trading_symbol": "CELU",
"owner_name": "Barach Daniele Wolf",
"is_director": false,
"is_officer": false,
"is_ten_percent_owner": true,
"is_other": false,
"security_type": "derivative",
"record_type": "holding",
"security_title": "Warrants",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"shares_owned_following_transaction": 1258740,
"exercise_price": 1.5,
"exercise_date": "2026-09-23",
"expiration_date": "2031-09-23",
"underlying_security_title": "Class A Common Stock",
"underlying_security_shares": 1258740,
"not_subject_to_section_16": false,
"direct_or_indirect": "I",
"nature_of_ownership": "See Footnote",
"footnotes": [
{
"id": "F3",
"description": "Represents the amendment and restatement on September 23, 2026 of existing warrants of the Issuer in which exercise price of such warrants was reduced from $2.00 per share to $1.50 per share and the termination date of such warrants was extended to September 23, 2031. No additional consideration was paid in connection with such amendment and restatement."
},
{
"id": "F2",
"description": "The Philip and Daniele Barach Family Trust (the \"Trust\") is or was the direct owner of all securities reported herein. The Reporting Person is a trustee of the Trust and has independent power to vote and dispose of all securities held by the Trust. The Reporting Person may be deemed to be an indirect beneficial owner of the securities held by the Trust, and the Reporting Person disclaims beneficial ownership of the securities held by the Trust except to the extent of the Reporting Person's pecuniary interest therein."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 21 records
- Option exercises3 records
- Tax withholding3 records
- Grants and awards15 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has Celularity Inc.'s CEO sold stock?
No. Robert J. Hariri (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is CELU’s insider data?
These are CELU Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track CELU insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for CELU every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.